CoChat

Escherichia coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-κ B-Mediated Activation of the MLCK-P-MLC Signaling Pathway

Open access
Guo, Shihao, Chen, Shanwen, Ma, Ju, Ma, Yongchen, Zhu, Jing, Ma, Yuanyuan, Liu, Yucun, Wang, Pengyuan, Pan, Yisheng · 2019 · Mediators of Inflammation

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Escherichia coli Nissle 1917 (EcN), a kind of probiotic, has been reported to have a protective effect on the intestinal barrier function and can ameliorate certain gastrointestinal disorders. In this study, the potential protective effect of EcN on the intestinal barrier function in a septic mouse model induced by cecal ligation and puncture (CLP) operation was investigated. FITC-Dextran 4,000 Da (FD-4) flux and the expression levels of tight junction (TJ) proteins were measured to evaluate the protective effect of EcN on the intestinal barrier function. Then, Caco-2 monolayers were utilized to further investigate the protective effect of the EcN supernatant (EcN sup) on the barrier dysfunction induced by TNF-α and IFN-γ in vitro; the plasma level of both the cytokines increased significantly during sepsis. Transepithelial electrical resistance (TEER) and FD-4 transmembrane flux were measured, and the localization of ZO-1 and Occludin was investigated by immunofluorescence. The expression of MLCK and the phosphorylation of MLC were detected by western blot. The activation of NF-κ B was explored by immunofluorescence, and CHIP assays were performed to investigate the conjunction of NF-κ B with the promoter of MLCK. The results indicated that EcN protected the intestinal barrier function in sepsis by ameliorating the altered expression and localization of TJ proteins and inhibiting the NF-κ B-mediated activation of the MLCK-P-MLC signaling pathway which might be one of the mechanisms underlying the effect of EcN.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2019/5796491

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The effect of EcN on mice with sepsis induced by CLP operation. (a) Food and water consumptions during the 14 days of oral gavage with saline or EcN (1 × 109 CFU/day). (b) The weight of mice after 14 days of oral gavage with saline or EcN (1 × 109 CFU/day). (c) FD-4 flux at 24 h after sham operation or CLP operation. (d) The mucosal cells of a mouse intestine were collected at 24 h after sham operation or CLP operation, and the total proteins were harvested followed by western blotting assays. Results were expressed as the mean ± SEM (n = 10). ∗P < 0.05 vs. the sham group. #P < 0.05 vs. the CLP group.
Figure 1 The effect of EcN on mice with sepsis induced by CLP operation. (a) Food and water consumptions during the 14 days of oral gavage with saline or EcN (1 × 109 CFU/day). (b) The weight of mice after 14 days of oral gavage with saline or EcN (1 × 109 CFU/day). (c) FD-4 flux at 24 h after sham operation or CLP operation. (d) The mucosal cells of a mouse intestine were collected at 24 h after sham operation or CLP operation, and the total proteins were harvested followed by western blotting assays. Results were expressed as the mean ± SEM (n = 10). ∗P < 0.05 vs. the sham group. #P < 0.05 vs. the CLP group.CC BY · PubMed Central
Figure 2 EcNsup attenuated the injury of intestinal barrier function induced by TNF-α/IFN-γ. (a) Caco-2 monolayers were incubated with or without 10 ng/mL TNF-α and 10 ng/mL IFN-γ in the presence or absence of 100, 300, and 600 ng/mL EcNsup for 48 h. EcNsup significantly attenuated the increase of FD-4 flux induced by TNF-α/IFN-γ treatment. (b) Caco-2 monolayers were incubated with or without 10 ng/mL TNF-α and 10 ng/mL IFN-γ in the presence or absence of 100 ng/mL EcNsup for 48 h. EcNsup significantly attenuated TEER reduction induced by TNF-α/IFN-γ treatment since 12 h. (c) Caco-2 monolayers were treated as described in (b). EcNsup significantly attenuated the increase of FD-4 flux induced by TNF-α/IFN-γ treatment since 12 h. Results were expressed as the mean ± SEM (n = 3). ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/IFN-γ.
Figure 2 EcNsup attenuated the injury of intestinal barrier function induced by TNF-α/IFN-γ. (a) Caco-2 monolayers were incubated with or without 10 ng/mL TNF-α and 10 ng/mL IFN-γ in the presence or absence of 100, 300, and 600 ng/mL EcNsup for 48 h. EcNsup significantly attenuated the increase of FD-4 flux induced by TNF-α/IFN-γ treatment. (b) Caco-2 monolayers were incubated with or without 10 ng/mL TNF-α and 10 ng/mL IFN-γ in the presence or absence of 100 ng/mL EcNsup for 48 h. EcNsup significantly attenuated TEER reduction induced by TNF-α/IFN-γ treatment since 12 h. (c) Caco-2 monolayers were treated as described in (b). EcNsup significantly attenuated the increase of FD-4 flux induced by TNF-α/IFN-γ treatment since 12 h. Results were expressed as the mean ± SEM (n = 3). ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/IFN-γ.CC BY · PubMed Central
Figure 3 EcNsup reversed the downregulation of TJ proteins induced by TNF-α/IFN-γ at both mRNA and protein levels. The total protein or RNA of monolayers was harvested after incubation for 48 h with or without 10 ng/mL TNF-α and 10 ng/mL IFN-γ in the presence or absence of 100 ng/mL EcNsup. The mRNA and protein level of ZO-1, Claudin-1, Claudin-2, and Occludin were tested by (a) RT-qPCR and (b) western blot, respectively. Results were expressed as the mean ± SEM (n = 3). ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/IFN-γ.
Figure 3 EcNsup reversed the downregulation of TJ proteins induced by TNF-α/IFN-γ at both mRNA and protein levels. The total protein or RNA of monolayers was harvested after incubation for 48 h with or without 10 ng/mL TNF-α and 10 ng/mL IFN-γ in the presence or absence of 100 ng/mL EcNsup. The mRNA and protein level of ZO-1, Claudin-1, Claudin-2, and Occludin were tested by (a) RT-qPCR and (b) western blot, respectively. Results were expressed as the mean ± SEM (n = 3). ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/IFN-γ.CC BY · PubMed Central
Figure 4 Immunofluorescence staining of Caco-2 cell monolayers grown on filters against ZO-1 and Occludin. (a1, a2, a3) In the control group, Caco-2 monolayers were treated with DMEM medium without TNF-α/IFN-γ or EcNsup. (b1, b2, b3) In the EcNsup group, Caco-2 monolayers were incubated with EcNsup for 48 h. (c1, c2, c3) In the TNF-α/IFN-γ group, Caco-2 monolayers were exposed to 10 ng/mL TNF-α and 10 ng/mL IFN-γ for 48 h. (d1, d2, d3) In the EcNsup+TNF-α/IFN-γ group, Caco-2 monolayers were incubated with 100 ng/mL EcNsup for 48 h in the presence of 10 ng/mL TNF-α and 10 ng/mL IFN-γ. The medium containing different reagents was changed every 12 h.
Figure 4 Immunofluorescence staining of Caco-2 cell monolayers grown on filters against ZO-1 and Occludin. (a1, a2, a3) In the control group, Caco-2 monolayers were treated with DMEM medium without TNF-α/IFN-γ or EcNsup. (b1, b2, b3) In the EcNsup group, Caco-2 monolayers were incubated with EcNsup for 48 h. (c1, c2, c3) In the TNF-α/IFN-γ group, Caco-2 monolayers were exposed to 10 ng/mL TNF-α and 10 ng/mL IFN-γ for 48 h. (d1, d2, d3) In the EcNsup+TNF-α/IFN-γ group, Caco-2 monolayers were incubated with 100 ng/mL EcNsup for 48 h in the presence of 10 ng/mL TNF-α and 10 ng/mL IFN-γ. The medium containing different reagents was changed every 12 h.CC BY · PubMed Central
Figure 5 EcNsup inhibited the increased expression of MLCK and the phosphorylation of MLC induced by TNF-α/IFN-γ. (a) The RNA of monolayers was harvested after incubation for 48 h in the absence or presence of 10 ng/mL TNF-α and 10 ng/mL IFN-γ with or without 100 ng/mL EcNsup, and the expression level of MLCK mRNA was detected by RT-qPCR. (b, c) The total protein of monolayers was harvested after treatment as described in (a), and the expression level of proteins was detected by western blot assays. Results were expressed as the mean ± SEM (n = 3). ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/IFN-γ.
Figure 5 EcNsup inhibited the increased expression of MLCK and the phosphorylation of MLC induced by TNF-α/IFN-γ. (a) The RNA of monolayers was harvested after incubation for 48 h in the absence or presence of 10 ng/mL TNF-α and 10 ng/mL IFN-γ with or without 100 ng/mL EcNsup, and the expression level of MLCK mRNA was detected by RT-qPCR. (b, c) The total protein of monolayers was harvested after treatment as described in (a), and the expression level of proteins was detected by western blot assays. Results were expressed as the mean ± SEM (n = 3). ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/IFN-γ.CC BY · PubMed Central
Figure 6 EcNsup suppressed the activation of NF-κB. (a) The nuclear protein of monolayers was harvested after incubation for 48 h in the absence or presence of 10 ng/mL TNF-α and 10 ng/mL IFN-γ with or without 100 ng/mL EcNsup followed by western blot assays. (b) Caco-2 monolayers were stained for NF-κB p65 by immunofluorescence. Cotreatment with 100 ng/mL EcNsup significantly inhibited the nuclear translocation of NF-κB p65 elicited by TNF-α/IFN-γ. A: The control group; B: Caco-2 monolayers were exposed to 100 ng/mL EcNsup for 30 min; C: Caco-2 monolayers were incubated with 10 ng/mL TNF-α and 10 ng/mL IFN-γ for 30 min; and D: Caco-2 monolayers were incubated with 100 ng/mL EcNsup for 30 min in the presence of 10 ng/mL TNF-α and 10 ng/mL IFN-γ. (c) Schematic illustration of human MLCK gene promoter containing two putative κB sites (κB-1 and κB-2) at -136 and -1451 as indicated. The PCR primer locations were also indicated. (d) Caco-2 cells were pretreated for 4 h with or without 100 ng/mL EcNsup in the absence or presence of 10 ng/mL TNF-α and 10 ng/mL IFN-γ. ChIP assays were performed with anti-p65 antibodies or IgG. The results for κB-1 and κB-2 sites are shown. Similar results were seen for 10 h treatment. Results were expressed as the mean ± SEM (n = 3). ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/IFN-γ.
Figure 6 EcNsup suppressed the activation of NF-κB. (a) The nuclear protein of monolayers was harvested after incubation for 48 h in the absence or presence of 10 ng/mL TNF-α and 10 ng/mL IFN-γ with or without 100 ng/mL EcNsup followed by western blot assays. (b) Caco-2 monolayers were stained for NF-κB p65 by immunofluorescence. Cotreatment with 100 ng/mL EcNsup significantly inhibited the nuclear translocation of NF-κB p65 elicited by TNF-α/IFN-γ. A: The control group; B: Caco-2 monolayers were exposed to 100 ng/mL EcNsup for 30 min; C: Caco-2 monolayers were incubated with 10 ng/mL TNF-α and 10 ng/mL IFN-γ for 30 min; and D: Caco-2 monolayers were incubated with 100 ng/mL EcNsup for 30 min in the presence of 10 ng/mL TNF-α and 10 ng/mL IFN-γ. (c) Schematic illustration of human MLCK gene promoter containing two putative κB sites (κB-1 and κB-2) at -136 and -1451 as indicated. The PCR primer locations were also indicated. (d) Caco-2 cells were pretreated for 4 h with or without 100 ng/mL EcNsup in the absence or presence of 10 ng/mL TNF-α and 10 ng/mL IFN-γ. ChIP assays were performed with anti-p65 antibodies or IgG. The results for κB-1 and κB-2 sites are shown. Similar results were seen for 10 h treatment. Results were expressed as the mean ± SEM (n = 3). ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/IFN-γ.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 64

Metadata

Authors
Guo, S., Chen, S., Ma, J., Ma, Y., Zhu, J., Ma, Y., Liu, Y., Wang, P., & Pan, Y.
Affiliations
  • Peking University (CN)
  • Division of General Surgery, Peking University First Hospital, Peking University, Beijing 100034, China
Corresponding author
Wang, Pengyuan
Venue
Mediators of Inflammation
Publisher
Wiley
Published
2019-07-03
Volume
2019
Pages
1-13
ISSN
  • 0962-9351 (ISSN-L)
  • 1466-1861
OpenAlex
W2955220684
Cited by
64
References
38
Citations by year
2026: 6 · 2025: 5 · 2024: 19 · 2023: 5 · 2022: 11 · 2021: 14 · 2020: 3 · 2019: 1
FWCI
5.60
Type
journal article
Language
en
Open access
Locations
  • Mediators of Inflammation (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
Keywords
Escherichia coli Nissle 1917, probiotics, intestinal barrier function, sepsis, NF-κB signaling, tight junction proteins, ZO-1, occludin, transepithelial electrical resistance, TNF-α, interferon-gamma, cecal ligation and puncture, Caco-2 cell monolayers
MeSH terms
Animals, Escherichia coli, Humans, Intestinal Mucosa, Male, Mice, Inbred C57BL, Phosphorylation, Blotting, Western, Signal Transduction, NF-kappa B, Sepsis, Caco-2 Cells, Tight Junctions, Mice, Transcription Factor RelA, Tight Junction Proteins, Occludin, Zonula Occludens-1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.